Abstract
Gerontology & Geriatrics Studies Longterm Mortality among Chronic Complex Patients with polypharmacy: Results of Community- Based Prospective Study Muria Subirats E1, Ballesta Ors J1, Clua Espuny JL1*, González Henares MA1, Queralt Tomas MLL1, Panisello Tafalla A1, Lucas Noll J1 and Gil Guillen VF2 1Health Department, Catalonian Health Institute, Generalitat de Catalunya, Spain 2Emotional Department, Cátedra Medicina de Familia, Spain *Corresponding author: Clua Espuny, J Luis EAP Tortosa Est, Institut Català Salut, SAP Terres de l'Ebre, Health Department, Generalitat de Catalunya, Plaça Carrilet, s/núm Tortosa 43500, Spain Submission: January 10, 2018; Published: February 09, 2018 DOI: 10.31031/GGS.2018.02.000529 ISSN : 2578-0093Volume2 Issue1
Highlights
The polypharmacy is common in ambulatory care, hospital and nursing home patients
Materials and Methods: We carried out a multicenter and prospective cohort study of mortality incidence from 01.01.2013 to 30.09.2016 among 825 adult patients registered in the electronic health record of Primary Care as Chronic Complex Outpatient
In the developed countries around 3-4% of the people could be identified as chronic complex patient and they are increasingly at risk of polypharmacy due to the need to treat the various disease states that develop as a patient ages
Summary
Over the last 20-30 years, problems related to aging, multi morbidity, and polypharmacy have become a prominent issue in global healthcare. In the developed countries around 3-4% of the people could be identified as chronic complex patient and they are increasingly at risk of polypharmacy due to the need to treat the various disease states that develop as a patient ages. The burden of taking multiple medications has been associated with greater health care costs and an increased risk of adverse drug events, druginteractions, medication non-adherence, reduced functional capacity and multiple geriatric syndromes. The prevention of these negative effects is of major importance because they engender significant morbidity and mortality. Nowadays the polypharmacy among older people are major issues for health and social care providers [4,5,6,7]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
